WO2009039102A8 - Inhibitors of copn (cpn) for the treatment of bacterial infections - Google Patents
Inhibitors of copn (cpn) for the treatment of bacterial infections Download PDFInfo
- Publication number
- WO2009039102A8 WO2009039102A8 PCT/US2008/076538 US2008076538W WO2009039102A8 WO 2009039102 A8 WO2009039102 A8 WO 2009039102A8 US 2008076538 W US2008076538 W US 2008076538W WO 2009039102 A8 WO2009039102 A8 WO 2009039102A8
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- copn
- cpn
- inhibitors
- bacterial infections
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4192—1,2,3-Triazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4365—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system having sulfur as a ring hetero atom, e.g. ticlopidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
This invention features compounds which are inhibitors of CopN(Cpn) and their use for treating bacterial infections in humans and animals.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US99410507P | 2007-09-17 | 2007-09-17 | |
| US60/994,105 | 2007-09-17 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| WO2009039102A1 WO2009039102A1 (en) | 2009-03-26 |
| WO2009039102A8 true WO2009039102A8 (en) | 2009-05-14 |
Family
ID=40468287
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PCT/US2008/076538 Ceased WO2009039102A1 (en) | 2007-09-17 | 2008-09-16 | Inhibitors of copn (cpn) for the treatment of bacterial infections |
Country Status (1)
| Country | Link |
|---|---|
| WO (1) | WO2009039102A1 (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6627686B1 (en) | 2000-09-06 | 2003-09-30 | The Goodyear Tire & Rubber Company | Diaryl-p-phenylenediamine disulfides |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9302016D0 (en) * | 1993-02-02 | 1993-03-17 | Sandoz Ltd | Compounds |
| JP3853985B2 (en) * | 1998-08-03 | 2006-12-06 | 有限会社 健康百二十才 | Disinfectant containing iron ions |
| WO2003039418A1 (en) * | 2001-11-06 | 2003-05-15 | Maxim Pharmaceuticals, Inc. | Compositions for the treatment of infectious diseases |
-
2008
- 2008-09-16 WO PCT/US2008/076538 patent/WO2009039102A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2009039102A1 (en) | 2009-03-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL213489A0 (en) | Compositions and methods for the treatment of the prevention of e. coli infections and for the eradication or reduction of e. coli surfaces | |
| WO2011047319A8 (en) | Antimicrobial compounds and methods of making and using the same | |
| WO2011047323A3 (en) | Antimicrobial compounds and methods of making and using the same | |
| TR200906131T1 (en) | Activin-actrIIa antagonists and treatment of breast cancer | |
| SI2079760T1 (en) | Compositions and methods for the treatment of infections | |
| WO2008124660A3 (en) | Methods and compositions for the treatment of cancer | |
| WO2010071846A3 (en) | Compounds for treating neuropsychiatric conditions | |
| UA118645C2 (en) | METHOD OF COMBINED CANCER THERAPY OF NANOPARTICLES CONTAINING RAPAMYCINE AND ALBUMIN | |
| AP2010005480A0 (en) | Small molecule inhibitors for the treatment or prevention of denque virus infection. | |
| WO2007120656A3 (en) | Uses and compositions for treatment of rheumatoid arthritis | |
| BRPI0807717A2 (en) | KINASE INHIBITORS USEFUL FOR TREATMENT OF MYELOPROLIFERATIVE DISEASES AND OTHER PROLIFERATIVE DISEASES. | |
| BRPI0818366A2 (en) | Compound, prodrug, drug, faah inhibitor method, methods of prophylaxis or treatment for anxiety or depression, or pain relief, and prophylaxis or treatment for inflammatory pain or neuropathic pain, and use of the compound. | |
| WO2007064872A3 (en) | Urea compounds useful in the treatment of cancer | |
| JO3235B1 (en) | Pyrrolopyrimidine compounds and their uses | |
| EP2273989A4 (en) | Combination therapy for the treatment of bacterial infections | |
| TNSN08400A1 (en) | Organic compounds and their uses | |
| BRPI0712607A8 (en) | stroke treatment methods | |
| WO2011047320A3 (en) | Antimicrobial compounds and methods of making and using the same | |
| WO2008153762A3 (en) | S-nitrosothiol formulations and storage systems | |
| WO2008019785A3 (en) | Transdermal application of triazines for controlling coccidia infections | |
| WO2007089612A3 (en) | Methods and compositions for treating and preventing bacterial infections | |
| MY165011A (en) | Antimicrobial compounds and methods of making and using the same | |
| WO2009009034A3 (en) | Methods and compositions useful in the treatment of mucositis | |
| GB0513096D0 (en) | Treatment of microbial infections | |
| WO2010065085A3 (en) | Methods and compositions for treating or preventing pruritis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 08831877 Country of ref document: EP Kind code of ref document: A1 |
|
| NENP | Non-entry into the national phase in: |
Ref country code: DE |
|
| 122 | Ep: pct application non-entry in european phase |
Ref document number: 08831877 Country of ref document: EP Kind code of ref document: A1 |